Mon, Mar 2, 2015, 12:21 AM EST - U.S. Markets open in 9 hrs 9 mins


% | $
Quotes you view appear here for quick access.

Enzon Pharmaceuticals Inc. Message Board

  • brainless_2004 brainless_2004 Dec 20, 2012 7:09 PM Flag

    I wonder why?

    Why would they stop R&D development, even though they have enough cash to keep on and are almost break even, if not positive? I does not make sense. This is usually done by companies that have burn their cash and are cash strapped, but they have $278M available, and $162M without debt.
    The only plausible answer is that they have a preliminary Sales Agreement that includes a multiplicative % of the cash available at the time of the sale. If this is so, maybe Merck is a suitable option, given that they would not need the R&D team.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.05-0.04(-3.67%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.